Incyte

United Therapeutics

Gilead Sciences

Natera

Alnylam Pharmaceuticals

Neurocrine Biosciences

Vertex Pharmaceuticals

Amgen

Insmed

Sarepta Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

SPDR S&P Bank ETF

SPDR Portfolio S&P 500 High Dividend ETF

Vanguard Russell 2000 Value ETF

SPDR S&P Retail ETF

As the U.S. economy is gaining momentum, the dips might charge investors to snap up stocks on the cheap, though they remained wary over inflation fears.

5 All-Star ETFs & Stocks to Buy on the Dip

ARK Innovation ETF

iShares MSCI Emerging Markets ETF

VanEck Vectors Gold Miners ETF

iShares iBoxx $ Investment Grade Corporate Bond ETF

iShares Silver Trust

iShares PHLX Semiconductor ETF

Vanguard Intermediate-Term Corporate Bond ETF

Energy Select Sector SPDR Fund

While last week was full of major corporate earnings and a Federal Reserve meeting, this week is no different with another flurry of corporate earnings. Investors may consider this week's top ETFs from Q.ai's deep learning algorithms to help diversify and mitigate risk.

AI Identifies ARK Innovation Among This Week's Trending ETFs

VanEck Vectors Biotech ETF

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

It definitely made investors a lot of money over the last decade. And its future could be brighter than the past.

Buying This Beaten-Down ETF Could Make You a Fortune Over the Next 10 Years

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Will Biotech ETFs React to These Q1 Earnings Releases?

ImmunityBio

Novavax

Ocugen, Inc.

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

BioNTech SE

Loncar China Biopharma ETF

Loncar Cancer Immunotherapy ETF

CRISPR Therapeutics

CureVac B.V

Editas Medicine

Moderna

Pfizer

Telesis Bio Inc

Here is what you should know about investing in these life changing technologies.

Best Biotech Stocks & ETFs for mRNA, Gene Editing

Given the recent selloff in biotech, there are plenty of busted biotech IPOs to choose from.

These 5 biotech ‘busted IPOs' look attractive now that the sectorwide selloff seems over

Biotech stocks surged last year in anticipation of a Covid vaccine and increased spending on healthcare by governments around the world, but a mix of regulatory factors are now pulling them back down.

After Roaring In 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays And Possible Drug Pricing Legislation

Virtus LifeSci Biotech Products ETF

Direxion Daily Healthcare Bull 3x Shares

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

abrdn Healthcare Investors 

abrdn Life Sciences Investors 

Defiance Nasdaq Junior Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Global X Longevity Thematic ETF

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Pacer BioThreat ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

Virtus LifeSci Biotech Clinical Trials ETF

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those aged 65 years and older.

Moving Beyond COVID In Biopharma

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Diagnosing The Future Of Healthcare

ALPS Medical Breakthroughs ETF

Biotechnology sector-related exchange traded funds could stumble in the near-term as increased regulatory scrutiny weighs on drugmakers. Among the hardest hit areas of Tuesday, the ALPS Medical Breakthroughs ETF (NYSEArca: SBIO) and SPDR S&P Biotech ETF (NYSEArca: XBI) both decreased 5.8% while the iShares Nasdaq Biotechnology ETF (IBB), the largest biotech-related ETF by assets, fell [.

Greater Regulatory Scrutiny Could Weigh on Biotech ETFs

Vir Biotechnology

Short-term investors may not see the long-term potential.

Here's Why Clinical-Stage Biotechs Get Hit Harder During a Market Decline

A dashboard with metrics in healthcare industries.

Healthcare Dashboard For March And Focus On XBI

They've both already made some investors a lot of money over the last few years.

2 High-Growth ETFs That Should Make You Rich Over the Next 10 Years

Global X Robotics & Artificial Intelligence ETF

ProShares Long Online/Short Stores ETF

Global X Cloud Computing ETF

Fidelity MSCI Materials Index ETF

Amplify Online Retail ETF

Johnson & Johnson

First Trust Nasdaq Artificial Intelligence & Robotics ETF

First Trust Cloud Computing ETF

Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.

5 ETF Investing Areas for March to Boost Returns

Roundhill Deep Value

First Trust Dow Jones Select MicroCap Index Fund

iShares U.S. Insurance ETF

iShares U.S. Oil & Gas Exploration & Production ETF

Global X Superdividend ETF

Given the jump in investors' sentiment, ETFs that still trade at bargain price seem excellent pick.

Stocks Off to a Solid Start in March: 6 Bargain ETF Picks

Boston Scientific

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

iShares iBoxx High Yield Corporate Bond ETF

iShares 7-10 Year Treasury Bond ETF

Invesco QQQ

iShares 20+ Year Treasury Bond ETF

Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.

Spiking Yields Pierce Bonds & Growth Stocks

ARK Fintech Innovation ETF

iShares MSCI EAFE Growth ETF

iShares China Large-Cap ETF

iShares Russell Mid-Cap Growth ETF

First Trust Indxx NextG ETF

Invesco WilderHill Clean Energy ETF

Vanguard Small-Cap Growth

Vanguard Information Technology ETF

Vanguard Growth ETF

These 13 growth ETFs allow investors to strive for hotter returns without overexposing themselves to one or two high-risk stocks.

13 Best Growth ETFs for a Rip-Roaring 2021

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

News for SPDR S&P Biotech ETF ETF (XBI)